Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

24
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
24
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

27
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
27
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

22
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
22
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

98
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
98
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

82
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
82
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

104
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopic Assistance Overestimates Resident Exposure to Vaginal Hysterectomy.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Benefits and harms of copyright restrictions and conditions on burnout and other psychometric assessment scales.

PloS one·2026
Same author

Gender and Burnout in Health Care Delivery - It's Complicated Cross-Sectional Study.

Kansas journal of medicine·2026
Same author

Understanding Outcomes and Barriers to Community Naloxone Distribution Programs: A Cross-Sectional Survey of Naloxone Recipients in Kansas.

Kansas journal of medicine·2026
Same author

Perspectives and Attitudes of Department of Obstetrics and Gynecology Sub-Internship Rotation Participants at a Single Academic Site: A Survey Study.

Kansas journal of medicine·2026
Same author

Comparing Genetic Testing Completion among Breast Cancer Patients When Ordered by a Surgeon Versus a Genetic Specialist.

Kansas journal of medicine·2026

Related Experiment Video

Updated: Oct 18, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

745

Bariatric Surgery Improves Renal Function in Patients With Obesity.

Oaklee L Abernathy1, Hayrettin Okut2, Bobbie G Paull-Forney3

  • 1Internal Medicine, Kansas University School of Medicine-Wichita, Wichita, USA.

Cureus
|October 4, 2021
PubMed
Summary

Weight loss through a multidisciplinary program before bariatric surgery significantly improved kidney function in adults with chronic kidney disease (CKD). This comprehensive approach reduced CKD progression and enhanced overall renal health.

Keywords:
bariatric and endocrine surgerybehavioral interventioncommunity-based weight loss interventionhypertensionimpaired renal functionkidney functionlifestyle interventionobesityweight lossweight loss and obesity

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K

Related Experiment Videos

Last Updated: Oct 18, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

745
Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K

Area of Science:

  • Nephrology
  • Bariatric Surgery
  • Metabolic Health

Background:

  • Obesity impacts 93.3 million US adults, a key factor in chronic kidney disease (CKD) development and progression.
  • Investigating weight loss interventions is crucial for managing obesity-related comorbidities like CKD.

Purpose of the Study:

  • To examine the association between weight loss and renal function in patients undergoing bariatric surgery.
  • To assess changes in secondary metabolic markers including hemoglobin A1c, lipids, glucose, and blood pressure.

Main Methods:

  • Retrospective chart review of 55 participants in a 12-week community-based weight loss program prior to bariatric surgery (2009-2018).
  • Primary outcome: association between weight loss and renal function (Glomerular Filtration Rate - GFR).
  • Secondary outcomes: changes in HbA1c, lipids, fasting glucose, and blood pressure.

Main Results:

  • Mean baseline GFR was 49 mL/min/m², with 80% female participants averaging 131 kg.
  • One year post-intervention, 69% improved CKD stage (45% from stage 3A to 2), with GFR increasing by 15 mL/min/1.73m² (p=0.025).
  • A negative correlation existed between weight and GFR (rs=-0.3556, p=0.013). Patients with hyperlipidemia saw a 12 mL/min/1.73m² GFR rise, while those without experienced a 24 mL/min/1.73m² rise (p=0.007).

Conclusions:

  • Combined lifestyle intervention and bariatric surgery significantly improved renal function and reduced CKD progression.
  • A comprehensive, multidisciplinary approach is vital for managing chronic kidney disease in obese populations.